allogenic placenta derived mesenchymal stem cells
Cell therapyexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Jul 23, 2019 (NCT06360861)
Timeline
Indications
Mechanism of action
- Stem CellSupplementation
Stem Cell supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06469411 | Phase 3 | Jan 1, 2023 | Tabriz Medical University |
| NCT06360861 | Phase 1 | Jul 23, 2019 | University of Tehran |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Tabriz Medical University | Academic/Hospital | 1 | 1 | 1 | 2023 |
| University of Tehran | Academic/Hospital | 1 | 1 | 1 | 2019 |
2 organizations
Page 1 / 1